Functional analysis of variants detected in SMAD1, SMAD4 and SMAD9, have shown impaired signalling in Smad4 and Smad9. However, variants only have a moderate impact on phenotype, suggesting further genetic or environmental hits may be required to induce PAH [54]. The gene discussed is SMAD1; the disease is pulmonary arterial hypertension.